Full Press Release Details
RETRACTABLE TECHNOLOGIES, INC. AMENDS HHS
LITTLE ELM, Texas, June 3,
2021-Retractable Technologies Inc. (NYSE American: RVP) announced today that it has entered into an amendment to delivery
order 75A50120F33003 from the Department of Health and Human Services which was awarded May 1, 2020. The amendment changes the
period of performance end date from May 2021 to March 2022 and reallocates the products ordered to increase shipments of
1mL low dead-space safety syringes. The previously disclosed total contract price and freight costs are unchanged.
more information on Retractable, visit its website at www.retractable.com.
Forward-looking statements in this press release
are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current
views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.
However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from
Factors that could cause or contribute to such
differences include, but are not limited to: the impact of COVID-19 on all facets of logistics and operations, as well as costs, Retractable's
ability to complete capital improvements and ramp up domestic production in response to government agreements, potential tariffs, Retractable's
ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party
manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's ability to access the market; production
costs; the impact of larger market players in providing devices to the safety market; and other risks and uncertainties that are detailed
from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange Commission.
Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President and Chief Financial Officer